flarex- fluorometholone acetate suspension/ drops
alcon laboratories, inc. - fluorometholone acetate (unii: 9i50c3i3ok) (fluorometholone - unii:sv0csg527l) - fluorometholone acetate 1 mg in 1 ml - flarex (fluorometholone acetate ophthalmic suspension) is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. contraindicated in acute superficial herpes simplex keratitis, vaccinia, varicella, and most other viral diseases of cornea and conjunctiva; mycobacterial infection of the eye; fungal diseases; acute purulent untreated infections, which like other diseases caused by microorganisms, may be masked or enhanced by the presence of the steroid; and in those persons who have known hypersensitivity to any component of this preparation.
fluorometholone- fluorometholone solution/ drops
remedyrepack inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fluorometholone ophthalmic suspension 0.1% is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluorometholone ophthalmic suspension 0.1% is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fluorometholone ophthalmic suspension 0.1% is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
fluorometholone solution/ drops
pacific pharma, inc. - fluorometholone (unii: sv0csg527l) (fluorometholone - unii:sv0csg527l) - fluorometholone ophthalmic suspension 0.1% is indicated for the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe. fluorometholone ophthalmic suspension 0.1% is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye, and fungal diseases of ocular structures. fluorometholone ophthalmic suspension 0.1% is also contraindicated in individuals with known or suspected hypersensitivity to any of the ingredients of this preparation and to other corticosteroids.
fml fluorometholone 1mg/ml eye drops bottle
abbvie pty ltd - fluorometholone, quantity: 1 mg/ml - eye drops, suspension - excipient ingredients: benzalkonium chloride; disodium edetate; sodium chloride; monobasic sodium phosphate; dibasic sodium phosphate heptahydrate; polysorbate 80; sodium hydroxide; purified water; polyvinyl alcohol - indications as at 23 oct 1995 : for steroid responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe.
fml liquifilm
abbvie biopharmaceuticals ltd, israel - fluorometholone - ophthalmic suspension - fluorometholone 0.1 %w/v - fluorometholone - fluorometholone - to treat eye inflammation.
sandoz fluorometholone suspension
sandoz canada incorporated - fluorometholone - suspension - 0.1% - fluorometholone 0.1% - corticosteroids
flarex- fluorometholone acetate suspension/ drops
eyevance pharmaceuticals - fluorometholone acetate (unii: 9i50c3i3ok) (fluorometholone - unii:sv0csg527l) - flarex (fluorometholone acetate ophthalmic suspension) 0.1% is indicated for use in the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the eye. contraindicated in acute superficial herpes simplex keratitis, vaccinia, varicella, and most other viral diseases of cornea and conjunctiva; mycobacterial infection of the eye; fungal diseases; acute purulent untreated infections, which like other diseases caused by microorganisms, may be masked or enhanced by the presence of the steroid; and in those persons who have known hypersensitivity to any component of this preparation.
pms-fluorometholone suspension
pharmascience inc - fluorometholone - suspension - 0.1% - fluorometholone 0.1% - corticosteroids
flucon
novartis new zealand ltd - fluorometholone 0.1%{relative} (+5% overage) - eye drops, suspension - 0.1% w/v - active: fluorometholone 0.1%{relative} (+5% overage) excipient: benzalkonium chloride dibasic sodium phosphate disodium edetate dihydrate hydrochloric acid hypromellose monobasic sodium phosphate monohydrate polysorbate 80 polyvinyl alcohol purified water sodium chloride sodium hydroxide
fml
abbvie limited - fluorometholone 1 mg/ml; - eye drops, solution - 0.1% w/v - active: fluorometholone 1 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate monobasic sodium phosphate monohydrate polysorbate 80 polyvinyl alcohol purified water sodium chloride sodium edetate sodium hydroxide